期刊文献+

慢性乙型肝炎患者血清甲状腺相关物质和IL-6检测及其临床意义 被引量:11

Serum thyroid-related substances and interleukin-6 levels in patients with chronic hepatitis B and liver cirrhosis
在线阅读 下载PDF
导出
摘要 目的研究慢性乙型肝炎病毒(Hepatitis B Virus,HBV)感染者血清甲状腺激素、抗甲状腺自身抗体及白细胞介素(interleukin,IL)-6水平变化及其临床意义。方法选取健康对照者18例、慢性乙型肝炎(CHB)患者65例和乙型肝炎肝硬化患者34例,应用电化学发光法分别检测并比较血清甲状腺激素水平、促甲状腺激素(TSH)、抗甲状腺相关抗体及IL-6水平。结果 CHB患者抗甲状腺过氧化物酶抗体(TPOAb)、抗甲状腺球蛋白抗体(TGAb)、抗促甲状腺激素受体抗体(TRAb)和IL-6水平分别为(9.5±5.6)KIU/L、(42.5±218.7)KIU/L、(1.5±0.7)IU/L和(6.6±12.6)pg/mL,在肝硬化患者分别为(9.5±8.6)KIU/L、(47.6±101.5)KIU/L、(2.2±1.7)IU/L和(15.8±25.5)pg/mL,均显著高于正常组[分别为(4.4±5.6)KIU/L、(7.7±18.3)KIU/L、(0.8±0.8)IU/L和(2.8±2.0)pg/mL,P<0.05],而CHB和肝硬化患者血FT3分别为(2.4±0.5)ng/L和(2.4±0.6)ng/L,均显著低于对照组[(2.9±0.2)ng/L,P<0.05];肝硬化患者TRAb和IL-6水平分别为(2.2±1.7)IU/L和(15.8±25.5)pg/mL,明显高于CHB患者[(1.5±0.7)IU/L和(6.6±12.6)pg/mL,P<0.05],而TT3和TT4水平分别为(0.8±0.3)nmol/L和(5.4±1.9)nmol/L,显著低于CHB患者[(1.3±0.3)nmol/L和(8.0±2.2)nmol/L,P<0.05]。结论联合检测慢性HBV感染者血清甲状腺激素、抗甲状腺自身抗体及IL-6水平对病情评价和预后判断有一定的临床价值。 Objective To investigate serum thyroid hormones,anti-thyroid autoantibodies and interleukin (IL)-6 levels and its clinical significance in patients with chronic hepatitis B virus(HBV) infection. Methods Eigh-teen healthy persons,65 patients with chronic hepatitis B (CHB)and 34 patients with hepatitis B liver cirrhosis were included in this study,and serum levels of thyroid hormones,anti-thyroid autoantibodies and IL-6 were de-termined by electrochemiluminescence. Results The serum levels of anti-thyroid peroxidase antibody(TPOAb),an-ti-thyroglobulin antibody (TGAb),anti-thyroid stimulating hormone receptor antibody (TRAb)and IL-6 in patients with CHB were (9.5±5.6) KIU/L,(42.5±218.7) KIU/L,(1.5±0.7) IU/L,and (6.6±12.6) pg/mL,respectively,and in cirrhotic patients were(9.5±8.6) KIU/L,(47.6±101.5) KIU/L,(2.2±1.7) IU/L and(15.8±25.5) pg/mL,respectively,all of which were significantly higher than those in normal controls[(4.4±5.6) KIU/L,(7.7±18.3) KIU/L,(0.8±0.8) IU/L and (2.8±2.0)pg/mL,respectively,P〈0.05],while FT3 in patients with CHB and cirrhotics were (2.4±0.5) ng/L and(2.4±0.6)ng/L,respectively,significantly lower than that in normal controls[(2.9±0.2) ng/L,P〈0.05];Serum TRAb and IL-6 levels in cirrhotic group were(2.2±1.7)IU/L and(15.8±25.5) pg/mL,respectively,significantly higher than that in patients with CHB [(1.5±0.7) IU/L and (6.6±12.6) pg/mL,respectively,P〈0.05],while serum TT3 and TT4 levels in cirrhotic group were(0.8±0.3)nmol/L and(5.4±1.9) nmol/L,respectively,significantly lower than those in CHB group [(1.3±0.3) nmol/L and(8.0±2.2) nmol/L,respectively,P〈0.05]. Conclusion Detection of serum thyroid hormon-es,anti-thyroid autoantibodies and IL-6 in patients with chronic HBV infection is of clinical significance in evalua-tion of the disease progress and prognosis.
出处 《实用肝脏病杂志》 CAS 2014年第1期48-50,共3页 Journal of Practical Hepatology
基金 2013年度福建省卫生厅青年基金资助课题(2013-1-45) 2013年度福建医科大学非附属医院科研专项基金项目(FZS13829Y) 2012年度泉州市科技计划项目(2012Z11)
关键词 慢性乙型肝炎 乙型肝炎肝硬化 甲状腺激素 抗甲状腺自身抗体 白细胞介素-6 INTERLEUKIN 6 Chronic hepatitis B Liver cirrhosis Thyroid hormones Anti-thyroid autoantibodies
作者简介 李菊兰,女,25岁,硕士研究生。主要从事病毒性肝炎的基础与临床研究。E—mail:494609874@qq.com 通讯作者:苏智军,E—mail:su2366@sina.com
  • 相关文献

参考文献15

二级参考文献40

  • 1黄增相,张惠泉,杨柳明,徐克诚.乙肝病毒携带者肝脏病理检查的临床价值[J].实用医学杂志,2005,21(11):1179-1180. 被引量:13
  • 2焦栓林,申德林,王全楚.慢性乙型隐匿型肝炎抗病毒治疗的初步探讨[J].临床肝胆病杂志,2005,21(2):115-115. 被引量:3
  • 3孙永良,张立煌,方海林,姚航平,林舜华李敏伟,王明海,何南祥,王季午.病毒性肝炎患者IL-1、IL-6和TNFα活性的检测[J].中华微生物学和免疫学杂志,1994,14(3):187-189. 被引量:30
  • 4董吉祥,陈永珍,刘志达,顾宗江,韩惠琴,郑列琳,张学光.慢性肾炎患者白细胞介素-6及T细胞亚群变化的探讨[J].标记免疫分析与临床,1994,1(2):76-78. 被引量:9
  • 5[1]Alessandro Antonelli,Clodoveo Ferri,Alessandro Pampana,et al.Thyroid disorders in chronic hepatitis C.The American Journal of Medicine,2004,117(1):10.
  • 6[2]Gallo V,Rabbia F,Pettion R,et al.Liver and thyroid:Physiopathologic and clinical relationships[J].Recent Prog Med,1992,81:351.
  • 7Ghoraishian SM,Hekmati Moghaddam SH,Afkhami-Ardekani M.Relationship between anti-thyroid peroxidase antibody and thyroid function test[J].Iran J Immunol,2006,3(3):146.
  • 8Eckstein A,Mann K,Kahaly GJ,et al.Role of TSH receptor autoantibodies for the diagnosis of Graves' disease and for the prediction of the course of hyperthyroidism and ophthalmopathy.Recommendations of the Thyroid Section of the German Society of Endocrinology[J].Med Klin(Munich),2009,104(5):343.
  • 9Laurberg P,Wallin G,Tallstedt L,et al.TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs,surgery,or radioiodine:a 5-year prospective randomized study[J].Eur J Endocrinol,2008,158(1):69.
  • 10Davies T, Marians R,Latff R..The TSH receptor reveals itself. J Clin Invest,2002,110:161 - 164.

共引文献472

同被引文献86

引证文献11

二级引证文献102

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部